MiRNA Deregulation in Cardiac Aging and Associated Disorders

Area of Science:

• Cardiovascular Biology
• Molecular Gerontology
• Biomedical Science

Background:

• Age-related cardiac diseases are a growing concern, with heart disease being the primary cause of mortality.
• Cardiac aging involves cellular and molecular alterations, including impaired signaling, mitochondrial dysfunction, and inflammation, leading to heart dysfunction.
• MicroRNAs (miRNAs) are critical regulators of cellular processes and are implicated in the detrimental changes observed during cardiac aging.

Purpose of the Study:

• To explore the role of miRNAs in cardiac aging and age-related heart dysfunction.
• To identify specific miRNAs involved in senescence and their contribution to cardiac aging.
• To evaluate the potential of miRNAs as therapeutic targets for stabilizing aged and failing hearts.

Main Methods:

• Review of existing literature on cardiac aging, molecular hallmarks, and miRNA regulation.
• Analysis of studies identifying deregulated miRNAs during senescence in cardiac tissues.
• Examination of the functional impact of specific miRNAs (e.g., MiR-34, MiR-146a, MiR-17-92 cluster) on cardiac aging processes.

Main Results:

• Cardiac aging is characterized by multiple molecular and cellular changes, including altered signaling pathways and increased cell death.
• MicroRNAs are significantly deregulated during cardiac senescence and actively contribute to the aging phenotype of the heart.
• Specific miRNAs, such as MiR-34, MiR-146a, and the MiR-17-92 cluster, are identified as key players in driving cardiac aging.

Conclusions:

• MicroRNAs play a fundamental role in the molecular mechanisms underlying cardiac aging and heart failure.
• The identified deregulated miRNAs offer promising avenues for therapeutic intervention in age-related cardiac conditions.
• Targeting specific miRNAs could be a viable strategy to stabilize the aged and failing myocardium.